Noteworthy, we uncovered a significant and persistent elevation in circulating levels of ApoC3 in plasma of PCOS mice at Week 2 compared to the control group (3.97±0.37 vs 2.88±0.10 μg/mL, P<0.01, Fig.3D). This evidence concerns the gene APOC3 and polycystic ovary syndrome.